235 related articles for article (PubMed ID: 17224047)
1. Urine carcinoembryonic antigen levels are more useful than serum levels for early detection of Bilharzial and non-Bilharzial urinary bladder carcinoma: observations of 43 Egyptian cases.
Saied GM; El-Metenawy WH; Elwan MS; Dessouki NR
World J Surg Oncol; 2007 Jan; 5():4. PubMed ID: 17224047
[TBL] [Abstract][Full Text] [Related]
2. Urine carcinoembryonic antigen determination in urinary bladder bilharziasis predicts carcinoma in patients with premalignant lesions: observation of 43 cases in Egypt.
Saied GM; El-Metenawy WH; Elwan MS; Dessouki NR
Tanzan Health Res Bull; 2006 Sep; 8(3):122-7. PubMed ID: 18254501
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation of RARbeta2 and APC genes in voided urine as molecular markers for early detection of bilharzial and nonbilharzial bladder cancer.
Eissa S; Swellam M; El-Khouly IM; Kassim SK; Shehata H; Mansour A; Esmat M; Nossier AI; Hamdy MA; Awad NM; El-Ahmady O
Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1657-64. PubMed ID: 21680534
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of urine cytology and urine carcinoembryonic antigen (CEA) level in the distinction between bladder cancer and urinary tract infection.
Gajda M; Tyloch F; Jóźwicki W; Tyloch J; Sujkowska R; Skok Z
Int J Occup Med Environ Health; 1995; 8(2):103-8. PubMed ID: 7582848
[TBL] [Abstract][Full Text] [Related]
6. The clinical value of CYFRA21-1 in bladder cancer patients: Egyptian experience.
el-Ahmady O; Halim AB; el-Din AG
Anticancer Res; 1999; 19(4A):2603-8. PubMed ID: 10470202
[TBL] [Abstract][Full Text] [Related]
7. Clinical usefulness of CEA, CA19-9, and CYFRA 21-1 as tumor markers for urothelial bladder carcinoma.
Washino S; Hirai M; Matsuzaki A; Kobayashi Y
Urol Int; 2011; 87(4):420-8. PubMed ID: 22041857
[TBL] [Abstract][Full Text] [Related]
8. The activities of urinary alpha-esterases in bilharziasis and their possible role in the diagnosis of bilharzial bladder cancer in Egypt.
el-Sewedy SM; Arafa A; Abdel-Aal G; Mostafa MH
Trans R Soc Trop Med Hyg; 1978; 72(5):525-8. PubMed ID: 726000
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic evaluation of apoptosis inhibitory gene and tissue inhibitor matrix metalloproteinase-2 in patients with bladder cancer.
Eissa S; Shabayek MI; Ismail MF; El-Allawy RM; Hamdy MA
IUBMB Life; 2010 May; 62(5):394-9. PubMed ID: 20408180
[TBL] [Abstract][Full Text] [Related]
10. Screening tests for the detection of bladder cancer.
Betkerur V; Hliang V; Baumgartner G; Rao R; Ablin RJ; Guinan PD
Allergol Immunopathol (Madr); 1980; 8(3):169-76. PubMed ID: 7405763
[TBL] [Abstract][Full Text] [Related]
11. Determination of carcinoembryonic antigen in tissue, serum and urine in patients with transitional cell carcinoma of the urinary bladder.
Jakse G; Rauschmeier H; Rosmanith P; Hofstädter F
Urol Int; 1983; 38(3):121-5. PubMed ID: 6868210
[TBL] [Abstract][Full Text] [Related]
12. Urinary leucine aminopeptidase in bilharziasis.
Khafagy EZ; El-Hawary MF; Galal AF; Salah MK; Shoeb ZM; Ibrahim KB; Omar S
Egypt J Bilharz; 1976; 3(2):199-212. PubMed ID: 1032292
[TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic antigen (CEA) in patients with malignant and non-malignant diseases.
Alsabti EA; Kamel A
Neoplasma; 1979; 26(5):603-9. PubMed ID: 230422
[TBL] [Abstract][Full Text] [Related]
14. [Urachal carcinoma producing carcinoembryonic antigen: a case report].
Arai Y; Konami T; Tomoyoshi T
Hinyokika Kiyo; 1989 Jun; 35(6):1065-8. PubMed ID: 2552778
[TBL] [Abstract][Full Text] [Related]
15. [Blood and urinary values of CEA and CA 19-9 in patients with bladder carcinoma].
Cicigoi A; Rocca Rossetti S; Piantino P; Cerchier A
Minerva Med; 1986 Nov; 77(42-43):1983-7. PubMed ID: 3464851
[TBL] [Abstract][Full Text] [Related]
16. [Urine determination of CEA, CA50 and TPA as tumor markers in bladder neoplasms].
Morote J; López-Pacios MA; Encabo G; de Torres JA
Med Clin (Barc); 1990 Jun; 95(3):119. PubMed ID: 2123505
[No Abstract] [Full Text] [Related]
17. Schistosomiasis and carcinoma of the bladder: a critical appraisal of causal relationship.
Attah EB; Nkposong EO
Trop Geogr Med; 1976 Dec; 28(4):268-72. PubMed ID: 1014066
[TBL] [Abstract][Full Text] [Related]
18. [Advances regarding tumor markers in bladder cancer].
Moreno Sierra J; Chicharro Almarza GJ; Torronteras Santiago JM; Ortega Heredia MD; Maestro de las Casas ML; Silmi Moyano A; Resel Estévez L
Actas Urol Esp; 1997 Mar; 21(3):195-205. PubMed ID: 9324884
[TBL] [Abstract][Full Text] [Related]
19. Assessment of serial CEA determinations in urine of patients with bladder carcinoma.
Zimmerman R; Wahren B; Edsmyr F
Cancer; 1980 Oct; 46(8):1802-9. PubMed ID: 7427883
[TBL] [Abstract][Full Text] [Related]
20. Utility of slot-blot-ELISA as a new, fast, and sensitive immunoassay for detection of carcinoembryonic antigen in the urine samples of patients with various gastrointestinal malignancies.
El-Masry S; El-Sayed IH; Lotfy M; Mahmoud L; El-Naggar M
J Immunoassay Immunochem; 2007; 28(2):91-105. PubMed ID: 17424828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
